Evidence map›Paper›PMID 2325650›Full record

ArticleMolecular and cellular biology1990

In vitro posttranslational modification of lamin B cloned from a human T-cell line.

K M Pollard, E K Chan, B J Grant, K F Sullivan, E M Tan, C A Glass

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Human airway epithelia express catalytically active NEU3 sialidase.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  8. Lamins at a glance.Journal of cell science · 2012
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K M PollardW. M. Keck Autoimmune Disease Center, La Jolla, California.
E K Chan
B J Grant
K F Sullivan
E M Tan
C A Glass
Autoimmune Technologies (United States) · US

Funding

AUTOIMMUNITY TO NUCLEAR ANTIGENSR01AR032063 · NIAMS · SCRIPPS CLINIC AND RESEARCH FOUNDATION · PI TAN, ENG M · 1986 to 1987
–
AUTOIMMUNITY TO NUCLEAR ANTIGENSR37AR032063 · NIAMS · SCRIPPS RESEARCH INSTITUTE · PI TAN, ENG M · 1988 to 1997
–
NIAMS NIH HHS AR32063
6 · The paper itself

Abstract

Autoimmune diseases are characterized by spontaneously occurring autoantibodies which have proven to be useful reagents for the characterization of specific nuclear proteins. Using a monoclonal autoantibody (72B9) derived from a murine lupus strain, we have cloned a cDNA from the human T-cell line MOLT-4, which encodes nuclear lamin B. The identity of the encoded protein as lamin B was established by both biochemical and immunological criteria. Inspection of the deduced amino acid sequence of lamin B revealed the presence in coil 1B of the alpha-helical domain of a leucine heptad repeat region. Analysis of mRNA in HL60 and MOLT-4 cells, which express only lamin B, or HeLa cells, which express all three major lamins (A, B, and C), together with the comigration of in vitro-translated product with isolated HeLa cell lamin B by two-dimensional gel electrophoresis, suggests that a single lamin B is expressed in mammalian somatic cells. In vitro translation with the cDNA clone revealed an EDTA-sensitive posttranslational modification which resulted in an increase in the apparent molecular weight to that equivalent to the native in vivo-synthesized lamin B protein. This in vitro modification included incorporation of a product of mevalonolactone and required an intact carboxy terminus.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAntibodies, MonoclonalBase SequenceBlotting, SouthernCell CompartmentationCell LineCloning, MolecularDNAElectrophoresis, Gel, Two-DimensionalHumansLaminsLamin Type BMolecular Sequence DataNuclear ProteinsProtein BiosynthesisAntibodies, MonoclonalDNALaminsLamin Type BNuclear Proteins

Identifiers

PMID2325650
PMCPMC360564
OpenAlexW1857662695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.